DiaMedica Therapeutics Inc. DMAC

Set alert

Price alert · DMAC

All alert types
9.29 USD +0.04 +0.43%

At close · Nov 2

9.29 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
9.30 × 2
Ask
9.31 × 2
8.96 Day range 9.51
5.25 52-week range 10.42
YTD
+16.71%
1 year
+31.59%
Open
9.33
Prev close
9.25
Mkt cap
500.97M
Vol
141.54K
Avg vol
185.28K
EPS
-0.72
P/E
0.00
Div yield
0.00%
More statistics
Low
8.96
High
9.51
Forward P/E
-7.26
Beta
1.46
Short ratio
3.88
Inst. own
31.61%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
4.69
200-d avg
3.61
1y target
7.00

5Y chart

Chart tools
Interval

Events in this range
  • Mar 19, 2024Earnings: -0.14; estimate -0.14; surprise 0%
  • Mar 21, 2024Rating: Oppenheimer · Outperform → Outperform
  • Mar 21, 2024Rating: Craig-Hallum · Buy → Buy
  • May 8, 2024Earnings: -0.14; estimate -0.16; surprise 12.5%
  • May 8, 2024Earnings: —; estimate -0.16; surprise —%
  • Aug 7, 2024Earnings: -0.13; estimate -0.16; surprise 18.75%
  • Aug 7, 2024Earnings: —; estimate -0.16; surprise —%
  • Aug 16, 2024Rating: Oppenheimer · Outperform → Outperform
  • Oct 7, 2024Rating: HC Wainwright & Co. · — → Buy
  • Oct 10, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 13, 2024Earnings: -0.15; estimate -0.15; surprise 0%
  • Nov 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (99)
NameDateAgo
SMA: BullishSep 14, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 7, 20261 month ago
SMA: BullishAug 31, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BearishJul 27, 20263 months ago
SMA: BearishJul 20, 20263 months ago
SMA: BullishJun 29, 20264 months ago
MACD: Buy SignalJun 29, 20264 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BearishFeb 23, 20268 months ago
SMA: BullishFeb 9, 20268 months ago
SMA: BearishJan 26, 20269 months ago
SMA: BullishJan 19, 20269 months ago
SMA: BearishJan 12, 20269 months ago
MACD: Sell SignalJan 12, 20269 months ago
RSI: OverboughtDec 8, 202510 months ago
SMA: BullishNov 17, 202511 months ago
MACD: Buy SignalNov 17, 202511 months ago
MACD: Sell SignalNov 10, 202511 months ago
SMA: BearishNov 3, 202512 months ago
SMA: BullishAug 4, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJul 21, 20251 year ago
MACD: Buy SignalJul 21, 20251 year ago
SMA: BullishJul 14, 20251 year ago
SMA: BearishJun 9, 20251 year ago
SMA: BullishMay 12, 20251 year ago
SMA: BearishMar 17, 20251 year ago
SMA: BearishMar 3, 20251 year ago
MACD: Sell SignalMar 3, 20251 year ago
RSI: OverboughtDec 16, 20241 year ago
RSI: OverboughtNov 25, 20241 year ago
SMA: BullishNov 18, 20241 year ago
MACD: Buy SignalNov 18, 20241 year ago
SMA: BearishNov 11, 20241 year ago
MACD: Sell SignalNov 11, 20241 year ago
MACD: Buy SignalJul 8, 20242 years ago
SMA: BullishJun 24, 20242 years ago
SMA: BullishJun 24, 20242 years ago
SMA: BearishJun 3, 20242 years ago
SMA: BearishJun 3, 20242 years ago
MACD: Sell SignalJun 3, 20242 years ago
MACD: Buy SignalMay 13, 20242 years ago
SMA: BullishApr 29, 20242 years ago
SMA: BullishApr 29, 20242 years ago
SMA: BearishApr 8, 20242 years ago
SMA: BearishApr 8, 20242 years ago
SMA: BullishApr 1, 20242 years ago
SMA: BullishMar 25, 20242 years ago
SMA: BearishMar 18, 20242 years ago
SMA: BearishMar 18, 20242 years ago
MACD: Sell SignalMar 18, 20242 years ago
SMA: BullishFeb 26, 20242 years ago
SMA: BearishFeb 19, 20242 years ago
SMA: BullishJan 29, 20242 years ago
SMA: BullishJan 29, 20242 years ago
SMA: BearishJan 22, 20242 years ago
SMA: BearishJan 15, 20242 years ago
SMA: BullishJan 8, 20242 years ago
MACD: Buy SignalDec 18, 20232 years ago
SMA: BullishNov 13, 20232 years ago
SMA: BearishSep 25, 20233 years ago
SMA: BearishSep 18, 20233 years ago
SMA: BullishSep 4, 20233 years ago
MACD: Sell SignalAug 7, 20233 years ago
SMA: BearishJul 24, 20233 years ago
RSI: OverboughtJun 5, 20233 years ago
RSI: OverboughtMay 22, 20233 years ago
SMA: BullishMay 15, 20233 years ago
SMA: BearishApr 24, 20233 years ago
SMA: BullishApr 17, 20233 years ago
SMA: BearishApr 10, 20233 years ago
SMA: BullishApr 3, 20233 years ago
SMA: BearishMar 20, 20233 years ago
SMA: BullishFeb 13, 20233 years ago
SMA: BullishFeb 13, 20233 years ago
SMA: BearishJan 23, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BearishJan 2, 20233 years ago
SMA: BullishDec 26, 20223 years ago
SMA: BullishNov 28, 20223 years ago
SMA: BearishSep 5, 20224 years ago
SMA: BullishAug 22, 20224 years ago
SMA: BearishAug 15, 20224 years ago
SMA: BullishAug 8, 20224 years ago
MACD: Buy SignalAug 8, 20224 years ago
MACD: Sell SignalJul 4, 20224 years ago
RSI: OversoldJul 4, 20224 years ago
RSI: OversoldJun 20, 20224 years ago
SMA: BearishJun 13, 20224 years ago
SMA: BullishJun 6, 20224 years ago
SMA: BearishMay 9, 20224 years ago
SMA: BullishMay 2, 20224 years ago
RSI: OversoldApr 4, 20224 years ago
SMA: BearishMar 28, 20224 years ago
SMA: BullishMar 14, 20224 years ago

Financial health

Altman Z-Score

37.17 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -11.4×
FY 2016: -4.7×FY 2017: -6.8×FY 2018: -3.9×FY 2019: -5.4×FY 2020: -13.0×FY 2021: -5.7×FY 2022: -3.0×FY 2023: -4.7×FY 2024: -9.1×FY 2025: -11.4×
FY 2016 5y median -5.7× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 45.1×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 6.7×
FY 2016: 8.4×FY 2017: 36.3×FY 2018: 1.3×FY 2019: 7.6×FY 2020: 6.1×FY 2021: 1.8×FY 2022: 1.3×FY 2023: 1.8×FY 2024: 5.4×FY 2025: 6.7×
FY 2016 5y median 1.8× FY 2025
P/FCF -12.9×
FY 2016: -3.4×FY 2017: -7.4×FY 2018: -3.9×FY 2019: -6.4×FY 2020: -17.2×FY 2021: -6.3×FY 2022: -3.6×FY 2023: -4.9×FY 2024: -9.9×FY 2025: -12.9×
FY 2016 5y median -6.3× FY 2025
EV/EBITDA -11.0×
FY 2016: -4.1×FY 2017: -6.5×FY 2018: -1.0×FY 2019: -4.7×FY 2020: -12.0×FY 2021: -5.4×FY 2022: -2.8×FY 2023: -4.6×FY 2024: -8.9×FY 2025: -11.0×
FY 2016 5y median -5.4× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 11.5×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -7.8%
FY 2016: -29.1%FY 2017: -13.5%FY 2018: -25.5%FY 2019: -15.7%FY 2020: -5.8%FY 2021: -15.8%FY 2022: -27.7%FY 2023: -20.3%FY 2024: -10.1%FY 2025: -7.8%
FY 2016 5y median -15.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -1352.2%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -1146.8%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -58.4%
FY 2016: -178.4%FY 2017: -533.2%FY 2018: -33.7%FY 2019: -139.8%FY 2020: -47.3%FY 2021: -30.9%FY 2022: -43.0%FY 2023: -38.0%FY 2024: -60.0%FY 2025: -58.4%
FY 2016 5y median -43.0% FY 2025
ROIC -61.0%
FY 2016: -199.2%FY 2017: -564.4%FY 2018: -39.7%FY 2019: -148.7%FY 2020: -48.6%FY 2021: -31.0%FY 2022: -43.4%FY 2023: -41.3%FY 2024: -65.0%FY 2025: -61.0%
FY 2016 5y median -43.4% FY 2025
ROA -53.4%
FY 2016: -118.7%FY 2017: -236.4%FY 2018: -31.3%FY 2019: -117.6%FY 2020: -43.8%FY 2021: -29.8%FY 2022: -39.8%FY 2023: -35.8%FY 2024: -52.7%FY 2025: -53.4%
FY 2016 5y median -39.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -28.9%
FY 2016: -89.5%FY 2017: -82.1%FY 2018: -49.6%FY 2019: -71.5%FY 2020: -9.5%FY 2021: -7.5%FY 2022: -2.6%FY 2023: -51.9%FY 2024: -25.5%FY 2025: -28.9%
FY 2016 FY 2025
EPS (diluted) -16.7%
FY 2016: -17.5%FY 2017: -53.2%FY 2018: -2.8%FY 2019: -20.3%FY 2020: 12.4%FY 2021: 16.7%FY 2022: 20.0%FY 2023: -15.4%FY 2024: 0.0%FY 2025: -16.7%
FY 2016 FY 2025
Free Cash Flow -31.7%
FY 2016: -121.0%FY 2017: -29.4%FY 2018: -46.5%FY 2019: -58.4%FY 2020: -1.4%FY 2021: -33.0%FY 2022: 5.6%FY 2023: -61.8%FY 2024: -17.9%FY 2025: -31.7%
FY 2016 FY 2025

Financial Health

Current Ratio 11.8×
FY 2016: 3.0×FY 2017: 1.5×FY 2018: 13.9×FY 2019: 6.7×FY 2020: 13.8×FY 2021: 29.8×FY 2022: 15.6×FY 2023: 19.3×FY 2024: 8.3×FY 2025: 11.8×
FY 2016 5y median 15.6× FY 2025
Quick Ratio 11.8×
FY 2016: 3.0×FY 2017: 1.5×FY 2018: 13.9×FY 2019: 6.7×FY 2020: 13.8×FY 2021: 29.8×FY 2022: 15.6×FY 2023: 19.3×FY 2024: 8.3×FY 2025: 11.8×
FY 2016 5y median 15.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.2×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 0.7×FY 2017: 0.3×FY 2018: 3.0×FY 2019: 0.3×FY 2020: 0.6×FY 2021: 0.3×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.5×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2016: -51.3×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31